{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:56:09Z","timestamp":1793411769549,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Science Foundation of Ningbo Municipality","award":["2021J296"],"award-info":[{"award-number":["2021J296"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81870255"],"award-info":[{"award-number":["81870255"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of the Zhejiang Province","award":["LY21H020001"],"award-info":[{"award-number":["LY21H020001"]}]},{"name":"Medical Health Science and Technology Project of Zhejiang Provincial Health Commission","award":["2021KY306"],"award-info":[{"award-number":["2021KY306"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The challenge posed by opioid overdose has become a significant concern for health systems due to the complexities associated with drug prohibition, widespread clinical use, and potential abuse. In response, healthcare professionals have primarily concentrated on mitigating the hallucinogenic and respiratory depressant consequences of opioid overdose to minimize associated risks. However, it is crucial to acknowledge that most opioids possess the capacity to prolong the QT interval, particularly in cases of overdose, thereby potentially resulting in severe ventricular arrhythmias and even sudden death if timely intervention is not implemented. Consequently, alongside addressing the typical adverse effects of opioids, it is imperative to consider their cardiotoxicity. To enhance comprehension of the correlation between opioids and arrhythmias, identify potential targets for prompt intervention, and mitigate the hazards associated with clinical utilization, an exploration of the interaction between drugs and ion channels, as well as their underlying mechanisms, becomes indispensable. This review primarily concentrates on elucidating the impact of opioid drugs on diverse ion channels, investigating recent advancements in this domain, and attaining a deeper understanding of the mechanisms underlying the prolongation of the QT interval by opioid drugs, along with potential interventions.<\/jats:p>","DOI":"10.1007\/s12012-024-09853-6","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T12:02:33Z","timestamp":1713355353000},"page":"472-480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Opioids-Induced Long QT Syndrome: A Challenge to Cardiac Health"],"prefix":"10.1007","volume":"24","author":[{"given":"Jiale","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichao","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanjin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beilei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangfang","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"9853_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jacep.2022.02.017","volume":"8","author":"AD Krahn","year":"2022","unstructured":"Krahn, A. D., et al. (2022). Congenital long QT syndrome.JACC: Clinical Electrophysiology,8, 687\u2013706.https:\/\/doi.org\/10.1016\/j.jacep.2022.02.017","journal-title":"JACC: Clinical Electrophysiology"},{"key":"9853_CR2","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.hrthm.2017.03.014","volume":"14","author":"H Yu","year":"2017","unstructured":"Yu, H., et al. (2017). Acquired long QT syndrome in hospitalized patients.Heart Rhythm,14, 974\u2013978.https:\/\/doi.org\/10.1016\/j.hrthm.2017.03.014","journal-title":"Heart Rhythm"},{"key":"9853_CR3","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/s0008-6363(02)00717-4","volume":"57","author":"C Ramakers","year":"2003","unstructured":"Ramakers, C., et al. (2003). Coordinated down-regulation of KCNQ1 and KCNE1 expression contributes to reduction of I(Ks) in canine hypertrophied hearts.Cardiovascular Research,57, 486\u2013496.https:\/\/doi.org\/10.1016\/s0008-6363(02)00717-4","journal-title":"Cardiovascular Research"},{"key":"9853_CR4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/s0008-6363(97)00274-5","volume":"37","author":"M Nabauer","year":"1998","unstructured":"Nabauer, M., & Kaab, S. (1998). Potassium channel down-regulation in heart failure.Cardiovascular Research,37, 324\u2013334.https:\/\/doi.org\/10.1016\/s0008-6363(97)00274-5","journal-title":"Cardiovascular Research"},{"key":"9853_CR5","doi-asserted-by":"publisher","first-page":"e2743","DOI":"10.1210\/clinem\/dgac195","volume":"107","author":"AD Kaze","year":"2022","unstructured":"Kaze, A. D., Yuyun, M. F., Erqou, S., Fonarow, G. C., & Echouffo-Tcheugui, J. B. (2022). Severe hypoglycemia and incidence of QT interval prolongation among adults with type 2 diabetes.The Journal of Clinical Endocrinology & Metabolism,107, e2743\u2013e2750.https:\/\/doi.org\/10.1210\/clinem\/dgac195","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"9853_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1159\/000492616","volume":"27","author":"M Behzadi","year":"2018","unstructured":"Behzadi, M., Joukar, S., & Beik, A. (2018). Opioids and cardiac arrhythmia: A literature review.Medical Principles and Practice,27, 401\u2013414.https:\/\/doi.org\/10.1159\/000492616","journal-title":"Medical Principles and Practice"},{"key":"9853_CR7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/cvr\/cvac103","volume":"119","author":"C Alexander","year":"2023","unstructured":"Alexander, C., et al. (2023). Initiation of ventricular arrhythmia in the acquired long QT syndrome.Cardiovascular Research,119, 465\u2013476.https:\/\/doi.org\/10.1093\/cvr\/cvac103","journal-title":"Cardiovascular Research"},{"key":"9853_CR8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ahj.2014.06.003","volume":"168","author":"B Darpo","year":"2014","unstructured":"Darpo, B., et al. (2014). Cardiac Safety Research Consortium: Can the thorough QT\/QTc study be replaced by early QT assessment in routine clinical pharmacology studies? Scientific update and a research proposal for a path forward.American Heart Journal,168, 262\u2013272.https:\/\/doi.org\/10.1016\/j.ahj.2014.06.003","journal-title":"American Heart Journal"},{"key":"9853_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10840-013-9779-5","volume":"37","author":"S Mahida","year":"2013","unstructured":"Mahida, S., et al. (2013). Genetics of congenital and drug-induced long QT syndromes: Current evidence and future research perspectives.Journal of Interventional Cardiac Electrophysiology,37, 9\u201319.https:\/\/doi.org\/10.1007\/s10840-013-9779-5","journal-title":"Journal of Interventional Cardiac Electrophysiology"},{"key":"9853_CR10","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.1073\/pnas.90.12.5391","volume":"90","author":"MJ Brownstein","year":"1993","unstructured":"Brownstein, M. J. (1993). A brief history of opiates, opioid peptides, and opioid receptors.Proceedings of the National Academy of Sciences USA,90, 5391\u20135393.https:\/\/doi.org\/10.1073\/pnas.90.12.5391","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"9853_CR11","unstructured":"UNODC. (2023). World Drug Report 2023 (United Nations publication)."},{"key":"9853_CR12","doi-asserted-by":"publisher","first-page":"690407","DOI":"10.3389\/fphar.2021.690407","volume":"12","author":"S Baby","year":"2021","unstructured":"Baby, S., et al. (2021). Systemic administration of tempol attenuates the cardiorespiratory depressant effects of fentanyl.Front Pharmacol,12, 690407.https:\/\/doi.org\/10.3389\/fphar.2021.690407","journal-title":"Front Pharmacol"},{"key":"9853_CR13","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1002\/ehf2.14101","volume":"9","author":"SM Liew","year":"2022","unstructured":"Liew, S. M., et al. (2022). Prescribed opioid use is associated with adverse cardiovascular outcomes in community-dwelling older persons.ESC Heart Failure,9, 3973\u20133984.https:\/\/doi.org\/10.1002\/ehf2.14101","journal-title":"ESC Heart Failure"},{"key":"9853_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13011-019-0196-3","volume":"14","author":"D Soroosh","year":"2019","unstructured":"Soroosh, D., Neamatshahi, M., Zarmehri, B., Nakhaee, S., & Mehrpour, O. (2019). Drug-induced prolonged corrected QT interval in patients with methadone and opium overdose.Substance Abuse Treatment, Prevention, and Policy,14, 8.https:\/\/doi.org\/10.1186\/s13011-019-0196-3","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"9853_CR15","doi-asserted-by":"publisher","first-page":"e0241362","DOI":"10.1371\/journal.pone.0241362","volume":"15","author":"PN Tran","year":"2020","unstructured":"Tran, P. N., et al. (2020). Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block.PLoS ONE,15, e0241362.https:\/\/doi.org\/10.1371\/journal.pone.0241362","journal-title":"PLoS ONE"},{"key":"9853_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023482","volume":"11","author":"MG Klein","year":"2022","unstructured":"Klein, M. G., et al. (2022). Methadone blockade of cardiac inward rectifier K(+) current augments membrane instability and amplifies U waves on surface ECGs: A translational study.Journal of the American Heart Association,11, e023482.https:\/\/doi.org\/10.1161\/JAHA.121.023482","journal-title":"Journal of the American Heart Association"},{"key":"9853_CR17","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1111\/bph.14348","volume":"175","author":"JE Meents","year":"2018","unstructured":"Meents, J. E., et al. (2018). The opioid oxycodone use-dependently inhibits the cardiac sodium channel Na(V) 1.5.British Journal of Pharmacology,175, 3007\u20133020.https:\/\/doi.org\/10.1111\/bph.14348","journal-title":"British Journal of Pharmacology"},{"key":"9853_CR18","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/cpt.2368","volume":"110","author":"S Solhjoo","year":"2021","unstructured":"Solhjoo, S., et al. (2021). Methadone destabilizes cardiac repolarization during sleep.Clinical Pharmacology & Therapeutics,110, 1066\u20131074.https:\/\/doi.org\/10.1002\/cpt.2368","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"9853_CR19","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.cjca.2022.04.005","volume":"38","author":"PE Wu","year":"2022","unstructured":"Wu, P. E., & Juurlink, D. N. (2022). Loperamide cardiac toxicity: Pathophysiology, presentation, and management.Canadian Journal of Cardiology,38, 1378\u20131383.https:\/\/doi.org\/10.1016\/j.cjca.2022.04.005","journal-title":"Canadian Journal of Cardiology"},{"key":"9853_CR20","doi-asserted-by":"publisher","first-page":"204512532211396","DOI":"10.1177\/20451253221139616","volume":"12","author":"A Shafi","year":"2022","unstructured":"Shafi, A., Berry, A. J., Sumnall, H., Wood, D. M., & Tracy, D. K. (2022). Synthetic opioids: a review and clinical update.Therapeutic Advances in Psychopharmacology,12, 20451253221139616.https:\/\/doi.org\/10.1177\/20451253221139616","journal-title":"Therapeutic Advances in Psychopharmacology"},{"key":"9853_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/qjmed\/hcs176","volume":"106","author":"I Berling","year":"2013","unstructured":"Berling, I., Whyte, I. M., & Isbister, G. K. (2013). Oxycodone overdose causes naloxone responsive coma and QT prolongation.QJM,106, 35\u201341.https:\/\/doi.org\/10.1093\/qjmed\/hcs176","journal-title":"QJM"},{"key":"9853_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1365-2125.2008.03327.x","volume":"67","author":"S Fanoe","year":"2009","unstructured":"Fanoe, S., Jensen, G. B., Sjogren, P., Korsgaard, M. P., & Grunnet, M. (2009). Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro.British Journal of Clinical Pharmacology,67, 172\u2013179.https:\/\/doi.org\/10.1111\/j.1365-2125.2008.03327.x","journal-title":"British Journal of Clinical Pharmacology"},{"key":"9853_CR23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ejphar.2015.06.016","volume":"762","author":"KH Tung","year":"2015","unstructured":"Tung, K. H., Angus, J. A., & Wright, C. E. (2015). Contrasting cardiovascular properties of the micro-opioid agonists morphine and methadone in the rat.European Journal of Pharmacology,762, 372\u2013381.https:\/\/doi.org\/10.1016\/j.ejphar.2015.06.016","journal-title":"European Journal of Pharmacology"},{"key":"9853_CR24","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1176\/appi.ajp.2013.12060860","volume":"170","author":"FR Girardin","year":"2013","unstructured":"Girardin, F. R., et al. (2013). Drug-induced long QT in adult psychiatric inpatients: The 5-year cross-sectional ECG Screening Outcome in Psychiatry study.American Journal of Psychiatry,170, 1468\u20131476.https:\/\/doi.org\/10.1176\/appi.ajp.2013.12060860","journal-title":"American Journal of Psychiatry"},{"key":"9853_CR25","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1345\/aph.1G524","volume":"40","author":"JR Baker","year":"2006","unstructured":"Baker, J. R., Best, A. M., Pade, P. A., & McCance-Katz, E. F. (2006). Effect of buprenorphine and antiretroviral agents on the QT interval in opioid-dependent patients.Annals of Pharmacotherapy,40, 392\u2013396.https:\/\/doi.org\/10.1345\/aph.1G524","journal-title":"Annals of Pharmacotherapy"},{"key":"9853_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1300\/J069v24n01_05","volume":"24","author":"MJ Krantz","year":"2005","unstructured":"Krantz, M. J., Rowan, S. B., & Mehler, P. S. (2005). Cocaine-related torsade de pointes in a methadone maintenance patient.Journal of Addictive Diseases,24, 53\u201360.https:\/\/doi.org\/10.1300\/J069v24n01_05","journal-title":"Journal of Addictive Diseases"},{"key":"9853_CR27","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1186\/s12877-021-02594-z","volume":"21","author":"TV Anand","year":"2021","unstructured":"Anand, T. V., Wallace, B. K., & Chase, H. S. (2021). Prevalence of potentially harmful multidrug interactions on medication lists of elderly ambulatory patients.BMC Geriatrics,21, 648.https:\/\/doi.org\/10.1186\/s12877-021-02594-z","journal-title":"BMC Geriatrics"},{"key":"9853_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/19336950.2020.1751522","volume":"14","author":"T Jenewein","year":"2020","unstructured":"Jenewein, T., et al. (2020). The mutation L69P in the PAS domain of the hERG potassium channel results in LQTS by trafficking deficiency.Channels (Austin),14, 163\u2013174.https:\/\/doi.org\/10.1080\/19336950.2020.1751522","journal-title":"Channels (Austin)"},{"key":"9853_CR29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1161\/CIRCGENETICS.109.898569","volume":"3","author":"E Nof","year":"2010","unstructured":"Nof, E., et al. (2010). A common single nucleotide polymorphism can exacerbate long-QT type 2 syndrome leading to sudden infant death.Circulation: Cardiovascular Genetics,3, 199\u2013206.https:\/\/doi.org\/10.1161\/CIRCGENETICS.109.898569","journal-title":"Circulation: Cardiovascular Genetics"},{"key":"9853_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugalcdep.2014.04.027","volume":"141","author":"A Hajj","year":"2014","unstructured":"Hajj, A., et al. (2014). KCNH2 polymorphism and methadone dosage interact to enhance QT duration.Drug and Alcohol Dependence,141, 34\u201338.https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.04.027","journal-title":"Drug and Alcohol Dependence"},{"key":"9853_CR31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/sj.clpt.6100120","volume":"81","author":"CB Eap","year":"2007","unstructured":"Eap, C. B., et al. (2007). Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers.Clinical Pharmacology & Therapeutics,81, 719\u2013728.https:\/\/doi.org\/10.1038\/sj.clpt.6100120","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"9853_CR32","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/archinternmed.2010.26","volume":"170","author":"N Ansermot","year":"2010","unstructured":"Ansermot, N., et al. (2010). Substitution of (R, S)-methadone by (R)-methadone: Impact on QTc interval.Archives of Internal Medicine,170, 529\u2013536.https:\/\/doi.org\/10.1001\/archinternmed.2010.26","journal-title":"Archives of Internal Medicine"},{"key":"9853_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jacc.2020.11.002","volume":"77","author":"MJ Krantz","year":"2021","unstructured":"Krantz, M. J., Palmer, R. B., & Haigney, M. C. P. (2021). Cardiovascular complications of opioid use: JACC state-of-the-art review.Journal of the American College of Cardiology,77, 205\u2013223.https:\/\/doi.org\/10.1016\/j.jacc.2020.11.002","journal-title":"Journal of the American College of Cardiology"},{"key":"9853_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/bja\/aer115","volume":"107","author":"N Dietis","year":"2011","unstructured":"Dietis, N., Rowbotham, D. J., & Lambert, D. G. (2011). Opioid receptor subtypes: Fact or artifact?British Journal of Anaesthesia,107, 8\u201318.https:\/\/doi.org\/10.1093\/bja\/aer115","journal-title":"British Journal of Anaesthesia"},{"key":"9853_CR35","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-med-062613-093100","volume":"67","author":"C Stein","year":"2016","unstructured":"Stein, C. (2016). Opioid receptors.Annual Review of Medicine,67, 433\u2013451.https:\/\/doi.org\/10.1146\/annurev-med-062613-093100","journal-title":"Annual Review of Medicine"},{"key":"9853_CR36","doi-asserted-by":"publisher","first-page":"13117","DOI":"10.1073\/pnas.1008382107","volume":"107","author":"HB Wang","year":"2010","unstructured":"Wang, H. B., et al. (2010). Coexpression of delta- and mu-opioid receptors in nociceptive sensory neurons.Proceedings of the National Academy of Sciences USA,107, 13117\u201313122.https:\/\/doi.org\/10.1073\/pnas.1008382107","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"9853_CR37","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/emmm.201201980","volume":"5","author":"D Nockemann","year":"2013","unstructured":"Nockemann, D., et al. (2013). The K(+) channel GIRK2 is both necessary and sufficient for peripheral opioid-mediated analgesia.EMBO Molecular Medicine,5, 1263\u20131277.https:\/\/doi.org\/10.1002\/emmm.201201980","journal-title":"EMBO Molecular Medicine"},{"key":"9853_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1039\/c0ib00107d","volume":"3","author":"LN Wei","year":"2011","unstructured":"Wei, L. N. (2011). The RNA superhighway: Axonal RNA trafficking of kappa opioid receptor mRNA for neurite growth.Integrative Biology (Camb),3, 10\u201316.https:\/\/doi.org\/10.1039\/c0ib00107d","journal-title":"Integrative Biology (Camb)"},{"key":"9853_CR39","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.2174\/138161212803582513","volume":"18","author":"C Stein","year":"2012","unstructured":"Stein, C., & Kuchler, S. (2012). Non-analgesic effects of opioids: Peripheral opioid effects on inflammation and wound healing.Current Pharmaceutical Design,18, 6053\u20136069.https:\/\/doi.org\/10.2174\/138161212803582513","journal-title":"Current Pharmaceutical Design"},{"key":"9853_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bja.2017.11.110","volume":"121","author":"SF He","year":"2018","unstructured":"He, S. F., et al. (2018). Cardiac mu-opioid receptor contributes to opioid-induced cardioprotection in chronic heart failure.British Journal of Anaesthesia,121, 26\u201337.https:\/\/doi.org\/10.1016\/j.bja.2017.11.110","journal-title":"British Journal of Anaesthesia"},{"key":"9853_CR41","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2174\/138945012799201612","volume":"13","author":"Y Feng","year":"2012","unstructured":"Feng, Y., et al. (2012). Current research on opioid receptor function.Current Drug Targets,13, 230\u2013246.https:\/\/doi.org\/10.2174\/138945012799201612","journal-title":"Current Drug Targets"},{"key":"9853_CR42","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.005851","volume":"12","author":"B Bozkurt","year":"2019","unstructured":"Bozkurt, B. (2019). Enkephalins and the opioid system of the heart.Circulation: Heart Failure,12, e005851.https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.119.005851","journal-title":"Circulation: Heart Failure"},{"key":"9853_CR43","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jhep.2005.02.043","volume":"43","author":"AR Hajrasouliha","year":"2005","unstructured":"Hajrasouliha, A. R., et al. (2005). Cholestatic liver disease modulates susceptibility to ischemia\/reperfusion-induced arrhythmia, but not necrosis and hemodynamic instability: The role of endogenous opioid peptides.Journal of Hepatology,43, 491\u2013498.https:\/\/doi.org\/10.1016\/j.jhep.2005.02.043","journal-title":"Journal of Hepatology"},{"key":"9853_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1478-3231.2012.02803.x","volume":"33","author":"L Moezi","year":"2013","unstructured":"Moezi, L., & Dehpour, A. R. (2013). Cardiovascular abnormalities in obstructive cholestasis: The possible mechanisms.Liver International,33, 7\u201315.https:\/\/doi.org\/10.1111\/j.1478-3231.2012.02803.x","journal-title":"Liver International"},{"key":"9853_CR45","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1152\/physrev.00024.2019","volume":"101","author":"A Varro","year":"2021","unstructured":"Varro, A., et al. (2021). Cardiac transmembrane ion channels and action potentials: Cellular physiology and arrhythmogenic behavior.Physiological Reviews,101, 1083\u20131176.https:\/\/doi.org\/10.1152\/physrev.00024.2019","journal-title":"Physiological Reviews"},{"key":"9853_CR46","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1152\/physrev.00008.2016","volume":"97","author":"MS Bohnen","year":"2017","unstructured":"Bohnen, M. S., et al. (2017). Molecular pathophysiology of congenital long QT syndrome.Physiological Reviews,97, 89\u2013134.https:\/\/doi.org\/10.1152\/physrev.00008.2016","journal-title":"Physiological Reviews"},{"key":"9853_CR47","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/bph.12465","volume":"171","author":"V Schulze","year":"2014","unstructured":"Schulze, V., et al. (2014). The opioid methadone induces a local anaesthetic-like inhibition of the cardiac Na(+) channel, Na(v)1.5.British Journal of Pharmacology,171, 427\u2013437.https:\/\/doi.org\/10.1111\/bph.12465","journal-title":"British Journal of Pharmacology"},{"key":"9853_CR48","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1093\/cvr\/cvz247","volume":"116","author":"MD Perry","year":"2020","unstructured":"Perry, M. D., et al. (2020). Pharmacological activation of IKr in models of long QT type 2 risks overcorrection of repolarization.Cardiovascular Research,116, 1434\u20131445.https:\/\/doi.org\/10.1093\/cvr\/cvz247","journal-title":"Cardiovascular Research"},{"key":"9853_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2023.03.006","author":"A El Sherbini","year":"2023","unstructured":"El Sherbini, A., et al. (2023). Opioids-induced inhibition of HERG ion channels and sudden cardiac death, a systematic review of current literature.Trends in Cardiovascular Medicine.https:\/\/doi.org\/10.1016\/j.tcm.2023.03.006","journal-title":"Trends in Cardiovascular Medicine"},{"key":"9853_CR50","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1124\/jpet.102.038240","volume":"303","author":"AN Katchman","year":"2002","unstructured":"Katchman, A. N., et al. (2002). Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents.Journal of Pharmacology and Experimental Therapeutics,303, 688\u2013694.https:\/\/doi.org\/10.1124\/jpet.102.038240","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"9853_CR51","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature04710","volume":"440","author":"MC Sanguinetti","year":"2006","unstructured":"Sanguinetti, M. C., & Tristani-Firouzi, M. (2006). hERG potassium channels and cardiac arrhythmia.Nature,440, 463\u2013469.https:\/\/doi.org\/10.1038\/nature04710","journal-title":"Nature"},{"key":"9853_CR52","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1124\/mol.112.081950","volume":"83","author":"M Richard-Lalonde","year":"2013","unstructured":"Richard-Lalonde, M., et al. (2013). Conformational dynamics of Kir31\/Kir32 channel activation via delta-opioid receptors.Molecular Pharmacology,83, 416\u2013428.https:\/\/doi.org\/10.1124\/mol.112.081950","journal-title":"Molecular Pharmacology"},{"key":"9853_CR53","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.hrthm.2017.04.001","volume":"14","author":"MG Klein","year":"2017","unstructured":"Klein, M. G., et al. (2017). Role of suppression of the inward rectifier current in terminal action potential repolarization in the failing heart.Heart Rhythm,14, 1217\u20131223.https:\/\/doi.org\/10.1016\/j.hrthm.2017.04.001","journal-title":"Heart Rhythm"},{"key":"9853_CR54","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.202112891","author":"P Angsutararux","year":"2021","unstructured":"Angsutararux, P., Kang, P. W., Zhu, W., & Silva, J. R. (2021). Conformations of voltage-sensing domain III differentially define NaV channel closed- and open-state inactivation.Journal of General Physiology.https:\/\/doi.org\/10.1085\/jgp.202112891","journal-title":"Journal of General Physiology"},{"key":"9853_CR55","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/cvr\/cvr252","volume":"93","author":"MB Rook","year":"2012","unstructured":"Rook, M. B., Evers, M. M., Vos, M. A., & Bierhuizen, M. F. (2012). Biology of cardiac sodium channel Nav1.5 expression.Cardiovascular Research,93, 12\u201323.https:\/\/doi.org\/10.1093\/cvr\/cvr252","journal-title":"Cardiovascular Research"},{"key":"9853_CR56","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00246-012-0303-y","volume":"33","author":"W Song","year":"2012","unstructured":"Song, W., & Shou, W. (2012). Cardiac sodium channel Nav15 mutations and cardiac arrhythmia.Pediatric Cardiology,33, 943\u2013949.https:\/\/doi.org\/10.1007\/s00246-012-0303-y","journal-title":"Pediatric Cardiology"},{"key":"9853_CR57","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euad209","author":"L Jia","year":"2023","unstructured":"Jia, L., Veldkamp, M. W., Verkerk, A. O., & Tan, H. L. (2023). The opioid tramadol blocks the cardiac sodium channel Nav1.5 in HEK293 cells.Europace.https:\/\/doi.org\/10.1093\/europace\/euad209","journal-title":"Europace"},{"key":"9853_CR58","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nrn3311","volume":"13","author":"AC Dolphin","year":"2012","unstructured":"Dolphin, A. C. (2012). Calcium channel auxiliary alpha2delta and beta subunits: Trafficking and one step beyond.Nature Reviews Neuroscience,13, 542\u2013555.https:\/\/doi.org\/10.1038\/nrn3311","journal-title":"Nature Reviews Neuroscience"},{"key":"9853_CR59","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1093\/europace\/euu063","volume":"16","author":"M Fukuyama","year":"2014","unstructured":"Fukuyama, M., et al. (2014). Long QT syndrome type 8: Novel CACNA1C mutations causing QT prolongation and variant phenotypes.Europace,16, 1828\u20131837.https:\/\/doi.org\/10.1093\/europace\/euu063","journal-title":"Europace"},{"key":"9853_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcdd9120431","volume":"9","author":"BC Lammoglia","year":"2022","unstructured":"Lammoglia, B. C., et al. (2022). Risk of cardiac lesion with chronic and acute use of loperamide-An integrative review.Journal of Cardiovascular Development and Disease,9, 1.https:\/\/doi.org\/10.3390\/jcdd9120431","journal-title":"Journal of Cardiovascular Development and Disease"},{"key":"9853_CR61","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1176\/appi.ajp.21080800","volume":"179","author":"H Tabuteau","year":"2022","unstructured":"Tabuteau, H., Jones, A., Anderson, A., Jacobson, M., & Iosifescu, D. V. (2022). Effect of AXS-05 (dextromethorphan-bupropion) in major depressive disorder: A randomized double-blind controlled trial.American Journal of Psychiatry,179, 490\u2013499.https:\/\/doi.org\/10.1176\/appi.ajp.21080800","journal-title":"American Journal of Psychiatry"},{"key":"9853_CR62","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s40263-022-00968-4","volume":"36","author":"SJ Keam","year":"2022","unstructured":"Keam, S. J. (2022). Dextromethorphan\/bupropion: First approval.CNS Drugs,36, 1229\u20131238.https:\/\/doi.org\/10.1007\/s40263-022-00968-4","journal-title":"CNS Drugs"},{"key":"9853_CR63","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ijcard.2010.09.024","volume":"148","author":"B Kaplan","year":"2011","unstructured":"Kaplan, B., Buchanan, J., & Krantz, M. J. (2011). QTc prolongation due to dextromethorphan.International Journal of Cardiology,148, 363\u2013364.https:\/\/doi.org\/10.1016\/j.ijcard.2010.09.024","journal-title":"International Journal of Cardiology"},{"key":"9853_CR64","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.biopha.2018.12.085","volume":"111","author":"M Subedi","year":"2019","unstructured":"Subedi, M., Bajaj, S., Kumar, M. S., & Yc, M. (2019). An overview of tramadol and its usage in pain management and future perspective.Biomedicine & Pharmacotherapy,111, 443\u2013451.https:\/\/doi.org\/10.1016\/j.biopha.2018.12.085","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"9853_CR65","doi-asserted-by":"publisher","first-page":"6918","DOI":"10.1038\/s41598-021-86321-z","volume":"11","author":"BJ Choi","year":"2021","unstructured":"Choi, B. J., et al. (2021). Risk of QT prolongation through drug interactions between hydroxychloroquine and concomitant drugs prescribed in real world practice.Scientific Reports,11, 6918.https:\/\/doi.org\/10.1038\/s41598-021-86321-z","journal-title":"Scientific Reports"},{"key":"9853_CR66","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/cpdd.473","volume":"8","author":"J Massarella","year":"2019","unstructured":"Massarella, J., et al. (2019). Tramadol hydrochloride at steady state lacks clinically relevant QTc interval increases in healthy adults.Clinical Pharmacology in Drug Development,8, 95\u2013106.https:\/\/doi.org\/10.1002\/cpdd.473","journal-title":"Clinical Pharmacology in Drug Development"},{"key":"9853_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules25173905","volume":"25","author":"L Sobczak","year":"2020","unstructured":"Sobczak, L., & Gorynski, K. (2020). Pharmacological aspects of over-the-counter opioid drugs misuse.Molecules,25, 1.https:\/\/doi.org\/10.3390\/molecules25173905","journal-title":"Molecules"},{"key":"9853_CR68","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s12012-020-09616-z","volume":"21","author":"J Wolfes","year":"2021","unstructured":"Wolfes, J., et al. (2021). Divergent electrophysiological effects of loperamide and naloxone in a sensitive whole-heart model.Cardiovascular Toxicology,21, 248\u2013254.https:\/\/doi.org\/10.1007\/s12012-020-09616-z","journal-title":"Cardiovascular Toxicology"},{"key":"9853_CR69","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jpain.2014.01.494","volume":"15","author":"R Chou","year":"2014","unstructured":"Chou, R., et al. (2014). Methadone safety: A clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society.The Journal of Pain,15, 321\u2013337.https:\/\/doi.org\/10.1016\/j.jpain.2014.01.494","journal-title":"The Journal of Pain"},{"key":"9853_CR70","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1161\/CIRCULATIONAHA.119.040162","volume":"140","author":"JE Salem","year":"2019","unstructured":"Salem, J. E., et al. (2019). Androgenic effects on ventricular repolarization: A translational study from the International Pharmacovigilance Database to iPSC-Cardiomyocytes.Circulation,140, 1070\u20131080.https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.040162","journal-title":"Circulation"},{"key":"9853_CR71","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1017\/erm.2022.43","volume":"25","author":"Y Yu","year":"2023","unstructured":"Yu, Y., Deschenes, I., & Zhao, M. T. (2023). Precision medicine for long QT syndrome: Patient-specific iPSCs take the lead.Expert Reviews in Molecular Medicine,25, e5.https:\/\/doi.org\/10.1017\/erm.2022.43","journal-title":"Expert Reviews in Molecular Medicine"},{"key":"9853_CR72","doi-asserted-by":"publisher","first-page":"114746","DOI":"10.1016\/j.bcp.2021.114746","volume":"192","author":"MVK Kamga","year":"2021","unstructured":"Kamga, M. V. K., Reppel, M., Hescheler, J., & Nguemo, F. (2021). Modeling genetic cardiac channelopathies using induced pluripotent stem cells-Status quo from an electrophysiological perspective.Biochemical Pharmacology,192, 114746.https:\/\/doi.org\/10.1016\/j.bcp.2021.114746","journal-title":"Biochemical Pharmacology"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-024-09853-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-024-09853-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-024-09853-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T15:10:05Z","timestamp":1715094605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-024-09853-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["9853"],"URL":"https:\/\/doi.org\/10.1007\/s12012-024-09853-6","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"assertion":[{"value":"28 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}